This domain may be for sale!
Location: United Kingdom, England, Vale of White Horse
Employees: 51-200
Founded date: 1996
Investors 3
Mentions in press and media 3
| Date | Title | Description |
| 09.09.2013 | Biotech accelerator BioMotiv, NYU unveil a new spinoff for inflammatory disease treatments | With funding from BioMotiv and NYU’s Innovation Venture Fund, Orca is working toward achieving proof of concept of an orally administered therapeutic for psoriasis in 2016. The announcement today did not disclose the amount of funding Orca ... |
| 24.11.2009 | UK, Oxagen Completes £16M Series C Financing Round | Oxagen Limited, a Milton Park, UK-based drug discovery and development company specializing in inflammation, completed a £16m ($26.7m) Series C round led by Novartis Venture Funds. Existing investors including MPM Capital, SV Life Sciences,... |
| - | Biotech accelerator BioMotiv, NYU unveil a new spinoff for inflammatory disease treatments | A biotech accelerator launched as part of a $250 million drug discovery initiative spearheaded by Cleveland’s University Hospitals has spun off its first company to develop promising technology for treating inflammatory diseases. Orca Pharm... |